Get started
Author

Jędrzej Borowczak

The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Biomedicines · 95
PDF
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Medical Oncology · 38
PDF
Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review
2023 · Marek Zdrenka, Adam Kowalewski, et al. · Biomolecules and Biomedicine · 31
PDF
Flow cytometry in the detection of circulating tumor cells in neoplastic effusions
2023 · Karol Gostomczyk, Ewelina Łukaszewska, et al. · Clinica Chimica Acta · 20
Targeting apoptosis in clear cell renal cell carcinoma
2024 · Adam Kowalewski, Jędrzej Borowczak, et al. · Biomedicine & Pharmacotherapy · 19
Targeting circulating tumor cells to prevent metastases
2023 · Karol Gostomczyk, Mohammed Dheyaa Marsool Marsool, et al. · Human Cell · 19
PDF
CDK9: Therapeutic Perspective in HCC Therapy
2020 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Current Cancer Drug Targets · 16
The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives
2024 · Dariusz Łaszczych, Aleksandra Czernicka, et al. · Medical Oncology · 12
Diagnostic biopsy does not accurately reflect the PD-L1 expression in triple-negative breast cancer
2023 · Marek Zdrenka, Adam Kowalewski, et al. · Clinical and Experimental Medicine · 11
PDF
Consolidative thoracic radiotherapy in the immunotherapy era for extensive-stage small cell lung cancer: a systematic review and meta-analysis with emphasis on brain and liver metastases
2025 · Dominik Wróbel, Bartosz Wojewoda, et al. · Radiotherapy and Oncology · 10
PDF
The Prognostic Role of CDK9 in Bladder Cancer
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Cancers · 9
PDF
Biomarkers for the detection of circulating tumor cells
2025 · Karol Gostomczyk, Magdalena Drozd, et al. · Experimental Cell Research · 8
Mechanisms of SARS-CoV-2 Placental Transmission
2023 · Karol Gostomczyk, Jędrzej Borowczak, et al. · Archivum Immunologiae et Therapiae Experimentalis · 8
PDF
Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma
2025 · Jędrzej Borowczak, Dariusz Łaszczych, et al. · Journal of Cancer Research and Clinical Oncology · 6
PDF
SARS-CoV-2 Infection during Delivery Causes Histopathological Changes in the Placenta
2024 · Jędrzej Borowczak, Agnieszka Gąsiorek-Kwiatkowska, et al. · Diseases · 6
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
2022 · Adam Kowalewski, Damian Jaworski, et al. · International Journal of Molecular Sciences · 6
PDF
Artificial Intelligence in Cervical Cytology: Opportunities and Limitations in Screening, Triage, and Diagnostic Support
2026 · Agata Stanek-Widera, Jędrzej Borowczak, et al. · Diagnostics · 4
Folate receptor alpha in platinum-resistant ovarian cancer: prevalence in a multicenter Polish cohort and review of the evidence
2025 · Jędrzej Borowczak, Justyna Durślewicz, et al. · Clinical & Translational Oncology · 4
PDF
High Expression of MRPL23 Is Associated with Poor Survival in Clear-Cell Renal Cell Carcinoma
2024 · Edyta Podemska, Jędrzej Borowczak, et al. · Cancers · 4
PDF
Atypical Presentation of Bronchogenic Cyst in the Retroperitoneal Space
2024 · Karol Gostomczyk, Jędrzej Borowczak, et al. · Cureus · 4
PDF
The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Clinical & Translational Oncology · 4
PDF
Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis—Pilot study
2022 · Paweł Solarz, Magdalena Bodnar, et al. · Journal of Medical Virology · 4
Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies
2024 · Jędrzej Borowczak, Dariusz Łaszczych, et al. · Pharmaceuticals · 3
PDF
PCMT1 as a prognostic marker in breast cancer
2024 · Patryk Rogaczewski, Michał Janiak, et al. · Clinical & Translational Oncology · 3
PDF
High MAL2 expression predicts shorter survival in women with triple-negative breast cancer
2024 · Jędrzej Borowczak, Marek Zdrenka, et al. · Clinical & Translational Oncology · 3
Works count: 53
Citation count: 358
H-index: 10
I10-index: 10
Year
Topic
Type